AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
Shoppers’ favorite FMCG brands – YouGov Brand Footprint 2025
The analysis is based on the CRP (Consumer Reach Points)…
Read more >Chicken is getting more expensive, eggs are getting more expensive – this is what awaits Hungarian consumers now
A significant price increase has taken place on the domestic…
Read more >Prices are soaring on the poultry market: chicken, turkey and eggs have also become more expensive
In recent months, a significant price increase has taken place…
Read more >